Literature DB >> 21833687

The expression and distribution of immunomodulatory proteins B7-H1, B7-DC, B7-H3, and B7-H4 in rheumatoid synovium.

Guoning Guo1, Yongjun Shang, Guoyan Zhu, Xiaoren Bao, Shiwei Xu, Yongwen Chen.   

Abstract

CD28/B7 signals have been shown to have the capacity to regulate T cell activation and participate in regulating the development of rheumatoid arthritis (RA). However, the expression and anatomical distribution of some members of the B7 superfamily including B7-H1, B7-DC, B7-H3 and B7-H4 in RA synovium is still unclear. We analyzed the expression of these molecules in synovial tissues from RA patients. Immunohistochemistry showed that all of these molecules were observed in synovium. On the cellular level, all of them were found on cell membrane and in cytoplasma. The expression of B7-DC and B7-H3 was major on capillaries, synovicytes and infiltrated inflammatory cells in the lining layer, while B7-H1 and B7-H4 were detected in some inflammatory cells residing in the sublining and lining layer. Fluorescent dual staining indicated that all these molecules were principally associated with CD31(+) endothelial cells and CD68(+) macrophages. In addition, B7-H1 and B7-H3 were also observed on CD3(+) T cells (including CD4(+) and CD8(+) T cells). Interestingly, B7-H1/B7-H4, B7-H3/B7-DC were co-expressed on the same cells. The characteristic expression and distribution of these molecules in synovium indicated that they probably have different effects during the progress of RA, and a clear understanding of their functional roles may further elucidate the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833687     DOI: 10.1007/s10067-011-1815-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

1.  The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.

Authors:  Amalia P Raptopoulou; George Bertsias; Dimitrios Makrygiannakis; Panagiotis Verginis; Iraklis Kritikos; Maria Tzardi; Lars Klareskog; Anca I Catrina; Prodromos Sidiropoulos; Dimitrios T Boumpas
Journal:  Arthritis Rheum       Date:  2010-07

Review 2.  New therapies in the management of rheumatoid arthritis.

Authors:  Maya H Buch; Paul Emery
Journal:  Curr Opin Rheumatol       Date:  2011-05       Impact factor: 5.006

Review 3.  Regulatory T cells as therapeutic targets in rheumatoid arthritis.

Authors:  Jonathan H Esensten; David Wofsy; Jeffrey A Bluestone
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

4.  Intracellular B7-H4 suppresses bile duct epithelial cell apoptosis in human primary biliary cirrhosis.

Authors:  Yongwen Chen; Guoning Guo; Sheng Guo; Shinji Shimoda; Kenneth R Shroyer; Yuyu Tang; Yuzhang Wu
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

5.  The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.

Authors:  Susana Salceda; Tenny Tang; Muriel Kmet; Andrei Munteanu; Malavika Ghosh; Roberto Macina; Wenhui Liu; Glenn Pilkington; Jackie Papkoff
Journal:  Exp Cell Res       Date:  2005-05-15       Impact factor: 3.905

6.  B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis.

Authors:  Keith M Hamel; Yanxia Cao; Yumei Wang; Rachel Rodeghero; Tamas Kobezda; Lieping Chen; Alison Finnegan
Journal:  Eur J Immunol       Date:  2010-10-27       Impact factor: 5.532

7.  Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3.

Authors:  Chinh N Tran; Seth G Thacker; Deanna M Louie; Jennifer Oliver; Peter T White; Judith L Endres; Andrew G Urquhart; Kevin C Chung; David A Fox
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

8.  Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.

Authors:  Peter Steinberger; Otto Majdic; Sophia V Derdak; Katharina Pfistershammer; Stefanie Kirchberger; Christoph Klauser; Gerhard Zlabinger; Winfried F Pickl; Johannes Stöckl; Walter Knapp
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

Review 9.  Fine tuning the immune response through B7-H3 and B7-H4.

Authors:  Kyung H Yi; Lieping Chen
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

10.  B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

Authors:  Xingluo Liu; Jian Xin Gao; Jing Wen; Lijie Yin; Ou Li; Tao Zuo; Thomas F Gajewski; Yang-Xin Fu; Pan Zheng; Yang Liu
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

View more
  7 in total

1.  Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts.

Authors:  Eri Sugawara; Masaru Kato; Yuki Kudo; Wenshi Lee; Ryo Hisada; Yuichiro Fujieda; Kenji Oku; Toshiyuki Bohgaki; Olga Amengual; Shinsuke Yasuda; Tomohiro Onodera; Shigetsugu Hatakeyama; Tatsuya Atsumi
Journal:  Autophagy       Date:  2019-09-08       Impact factor: 16.016

2.  The expression and anatomical distribution of BTLA and its ligand HVEM in rheumatoid synovium.

Authors:  Yongjun Shang; Guoning Guo; Qifu Cui; Jinlong Li; Zhihua Ruan; Yongwen Chen
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  A Potential Role of B7-H4 Expression in Predicting the Recurrence of Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Fengjun Wang; Wei Chu; Zhenghao Deng; Qiancheng Jing; Bin Xie
Journal:  J Inflamm Res       Date:  2022-06-09

Review 4.  B7-H4's role "beyond the tumor".

Authors:  Ning Yu; Xiaomei Li; Songguo Zheng; Xiangpei Li
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 5.  Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.

Authors:  Sabrina Ceeraz; Elizabeth C Nowak; Christopher M Burns; Randolph J Noelle
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

Review 6.  Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases.

Authors:  Elena V Gerasimova; Dmitry V Tabakov; Daria A Gerasimova; Tatiana V Popkova
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

7.  The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276.

Authors:  Ruidong Li; Pavlina Zatloukalova; Petr Muller; Maria Gil-Mir; Sachin Kote; Simon Wilkinson; Alain J Kemp; Lenka Hernychova; Yaxin Wang; Kathryn L Ball; Kaixiong Tao; Ted Hupp; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2020-08-31       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.